Selected Publications

View a full list of publications

  1. Reddy KP, Eberly LA, Halaby R, Julien H, Khatan SAM, Dayoub EJ, Coylewright M, Alkhouli M, Fiorilli PN, Kobayashi TJ, Goldberg DM, Santangeli P, Herrmann HC, Giri J, Groeneveld PW, Fanaroff AC, Nathan AS. Racial, Ethnic, Socioeconomic, and Geographic Inequities in Access to Left Atrial Appendage Occlusion (LAAO). JAHA. 2023.
  2. Nathan AS, Reddy KP, Yang L, Eberly LA, Dayoub EJ, Khatana SAM, Julien HM, Desai ND, Szeto WY, Herrmann HC, Kobayashi TJ, Fiorilli P, Batchelor WB, Mehran R, Alkhouli MA, Giri J, Groeneveld PW, Fanaroff AC. Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies. JAMA Cardiol. 2023
  3. Reddy KP, Groeneveld PW, Giri J, Fanaroff AC, Nathan AS. Economic Considerations in Access to Transcatheter Aortic Valve Replacement. Circ Cardiovasc Interv. 2022
  4. Eberly LA, Julien H, South EC, Venkataraman A, Nathan AS, Anyawu EC, Dayoub E, Groeneveld PW, Khatana SAM. Association Between Community-Level Violent Crime and Cardiovascular Mortality in Chicago: A Longitudinal Analysis. J Am Heart Assoc. 2022
  5. Nathan AS, Geng Z, Eberly LA, Eneanya ND, Dayoub EJ, Khatana SAM, Kolansky DM, Kobayashi TJ, Tuteja S, Fanaroff AC, Giri J, Groeneveld PW. Identifying Racial, Ethnic, and Socioeconomic Inequities in the Use of Novel P2Y12 Inhibitors After Percutaneous Coronary Intervention. J Invasive Cardiol. 2022
  6. McCaffrey JA, Dhakal BP, Nathan AS, Ortega-Legaspi J, Fiorilli PN, Mather PJ, Supple GE. Loss of Right Atrial Pacing Lead Capture Due to Myocardial Infarction Obscuring Diagnosis on Electrocardiogram. JACC Case Rep. 2022
  7. Nathan AS, Yang L, Yang N, Eberly LA, Khatana SAM, Dayoub EJ, Vemulapalli S, Julien H, Cohen DJ, Nallamothu BK, Baron SJ, Desai ND, Szeto WY, Herrmann HC, Groeneveld PW, Giri J, Fanaroff AC. Racial, Ethnic and Socioeconomic Inequities in Access to Transcatheter Aortic Valve Replacement within Major Metropolitan Areas. JAMA Cardiol. 2022
  8. Johnson BV, Horton ER, Domenico C, Nathan AS, Fanaroff AC, Acker MA, Kolansky DM. Safety of Intravenous Cangrelor Administration for Antiplatelet Bridging in Hospitalized Patients: A Retrospective Study. J Invasive Cardiol. 2021
  9. Jamil A, Johnston-Cox H, Pugliese S, Nathan AS, Fiorilli P, Khandhar S, Weinberg MD, Giri J, Kobayashi T. Current interventional therapies in acute pulmonary embolism. Prog Cardiovasc Dis. 2021
  10. Nathan AS, Manandhar P, Wojdyla D, Fiorilli P, Waldo S, Yeh SV, Nelson A, Fanaroff AC, Groeneveld PW, Wang TY, Giri J. Hospital-Level Percutaneous Coronary Intervention Performance with a Simulated Risk Avoidance Strategy. J Am Coll Cardiol. 2021
  11. Nathan AS, Yang L, Yang N, Khatana SAM, Dayoub EJ, Eberly LA, Vemulapalli S, Baron SJ, Cohen DJ, Desai ND, Bavaria JE, Herrmann HC, Groeneveld PW, Giri J, Fanaroff AC. Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012–2018. Circ Cardiovasc Qual Outcomes. 2021
  12. Fanaroff AC, Yang L, Nathan AS, Khatana SAM, Julien H, Wang TY, Armstrong EJ, Treat-Jacobson D, Glaser JD, Wang G, Damrauer SM, Giri J, Groeneveld PW. Geographic and Socioeconomic Disparities in Major Lower Extremity Amputation Rates in Metropolitan Areas. J Am Heart Assoc. 2021
  13. Halaby R, Giri J, Herrmann HC, Kobayashi TJ, Fiorilli PF, Fanaroff AC, Nathan AS. Lack of Association Between Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement Outcomes in New York Hospitals. Circ Cardiovasc Interv. 2021
  14. Nathan AS, Giri J, Fanaroff A. Reporting of Percutaneous Coronary Interventions Site-Specific Mortality-Reply. JAMA Cardiol. 2021
  15. Khatana SAM, Hanff TC, Nathan AS, Dayoub EJ, Grandin EW, Rame JE, Fanaroff AC, Giri J, Groeneveld PW. Association of Health Insurance Payer Type and Outcomes After Durable Left Ventricular Assist Device Implantation: An Analysis of the STS-INTERMACS Registry. Circ Heart Fail. 2021
  16. Dayoub EJ, Eberly LA, Nathan AS, Khatana SAM, Adusumalli S, Navar AM, Giri J, Groeneveld PW. Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease. J Am Heart Assoc. 2021
  17. Julien HM, Stebbins A, Vemulapalli S, Nathan AS, Eneanya ND, Groeneveld P, Fiorilli PN, Herrmann HC, Szeto WY, Desai ND, Anwaruddin S, Vora A, Shah B, Ng VG, Kumbhani DJ, Giri J. Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology National Cardiovascular Data Registry-Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv. 2021
  18. Eberly LA, Yang L, Eneanya ND, Essien U, Julien H, Nathan AS, Khatana SAM, Dayoub EJ, Fanaroff AC, Giri J, Groeneveld PW, Adusumalli S. Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US. JAMA Netw Open. 2021
  19. Dayoub EJ, Nathan AS, Khatana SAM, Wadhera RK, Kolansky DM, Yeh RW, Giri J, Groeneveld PW. Trends in Coded Indications for Percutaneous Coronary Interventions in Medicare and the Veterans Affairs After Implementation of Hospital-Level Reporting of Appropriate Use Criteria. Circ Cardiovasc Qual Outcomes. 2021
  20. Eberly LA, Garg L, Yang L, Markman TM, Nathan AS, Eneanya ND, Dixit S, Marchlinski FE, Groeneveld PW, Frankel DS. Racial/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation. JAMA Netw Open. 2021
  21. Eberly LA, Yang L, Essien UR, Eneanya ND, Julien HM, Luo J, Nathan AS, Khatana SAM, Dayoub EJ, Fanaroff AC, Giri J, Groeneveld PW, Adusumalli S. Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US. JAMA Health Forum. 2021
  22. Khatana SAM, Venkataramani AS, Nathan AS, Dayoub EJ, Eberly LA, Kazi DS, Yeh RW, Mitra N, Subramanian SV, Groeneveld PW. Association Between County-Level Change in Economic Prosperity and Change in Cardiovascular Mortality Among Middle-aged US Adults. JAMA. 2021
  23. Nathan AS, Yang L, Geng Z, Dayoub EJ, Khatana SAM, Fiorilli PN, Herrmann HC, Szeto WY, Atluri P, Acker MA, Desai ND, Frankel DS, Marchlinski FE, Fanaroff AC, Giri J, Groeneveld PW. Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair. Am Heart J. 2021
  24. Yang N, Groeneveld PW, Khatana SAM, Giri J, Fanaroff AC, Nathan AS. Variability in Reported Percutaneous Coronary Intervention Mortality Among Physicians Practicing at Multiple Sites in New York State. JAMA Cardiol. 2021
  25. Nathan AS*, Martinez J*, Giri J, Navathe AS. Observational study assessing changes in timing of readmissions around postdischarge day 30 associated with the introduction of the Hospital Readmissions Reduction Program BMJ Qual Saf. 2021
  26. Eberly LA, Kallan MJ, Julien HM, Haynes N, Khatana SAM, Nathan AS, Snider C, Chokshi NP, Eneanya ND, Takvorian SU, Anastos-Wallen R, Chaiyachati K, Ambrose M, O'Quinn R, Seigerman M, Goldberg LR, Leri D, Choi K, Gitelman Y, Kolansky DM, Cappola TP, Ferrari VA, Hanson CW, Deleener ME, Adusumalli S. Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic. JAMA Netw Open. 2020
  27. Pothineni NVK, Starkey S, Conn K, Evans C, Shah R, Hyman MC, Frankel DS, Halaby R, Johnston-Cox HA, Kunkel K, Nathan AS, Seigerman ME, Herrmann HC, Giri J, Marchlinski FE, Santangeli P, Fanaroff AC. Patient and Staff Perceptions of Universal Severe Acute Respiratory Syndrome Coronavirus 2 Screening Prior to Cardiac Catheterization and Electrophysiology Laboratory Procedures. Circ Cardiovasc Interv. 2020
  28. Nathan AS, Yang L, Geng Z, Dayoub EJ, Khatana SAM, Fiorilli PN, Herrmann HC, Szeto WY, Atluri P, Acker MA, Desai ND, Frankel DS, Marchlinski FE, Fanaroff AC, Giri J, Groeneveld PW. Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair. Am Heart J. 2020
  29. Nathan AS, Raman S, Yang N, Painter I, Khatana SAM, Dayoub EJ, Herrmann HC, Yeh RW, Groeneveld PW, Doll JA, McCabe JM, Hira RS, Giri J, Fanaroff AC. Association Between 90-Minute Door-to-Balloon Time, Selective Exclusion of Myocardial Infarction Cases, and Access Site Choice: Insights from the Cardiac Care Outcomes Assessment Program (COAP) in Washington State. Circulation Cardiovasc Int. 2020
  30. Selvaraj S, Greene SJ, Khatana SAM, Nathan AS, Solomon SD, Bhatt DL. The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID-19. J Am Heart Assoc. 2020
  31. Eberly LA, Khatana SAM, Nathan AS, Snider C, Julien HM, Deleener ME, Adusumalli S. Telemedicine Outpatient Cardiovascular Care During the COVID-19 Pandemic: Bridging or Opening the Digital Divide? Circulation. 2020
  32. Nathan AS, Xiang Q, Wojdyla D, Khatana SAM, Dayoub EJ, Wadhera RK, Bhatt DL, Kolansky DM, Kirtane AJ, Rao SV, Yeh RW, Groeneveld PW, Wang TY, Giri J. Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction. JAMA Cardiol. 2020
  33. Geller BJ, Adusumalli S, Pugliese SC, Khatana SAM, Nathan AS, Weinberg I, Jaff MR, Kobayashi T, Mazurek JA, Khandhar S, Yang L, Groeneveld PW, Giri JS. Outcomes of Catheter-Directed Versus Systemic Thrombolysis for the Treatment of Pulmonary Embolism: A Real-World Analysis of National Administrative Claims. Vasc Med. 2020
  34. Dayoub EJ, Medvedeva EL, Khatana SAM, Nathan AS, Epstein AJ, Groeneveld PW. Federal Payments for Coronary Revascularization Procedures Among Dual Enrollees in Medicare Advantage and the Veterans Affairs Health Care System. JAMA Netw Open. 2020
  35. Nathan AS, Blebea C, Chatterjee P, Thomasson A, Diamond JM, Groeneveld PW, Giri J, Goldberg HJ, Courtwright AM. Mortality Trends Around the One-Year Survival Mark After Heart, Liver, and Lung Transplantation in the United States. Clin Transplant. 2020
  36. Tuteja S, Glick H, Matthai W, Nachamkin I, Nathan AS, Monono K, Carcuffe C, Maslowski K, Chang G, Kobayashi T, Anwaruddin S, Hirshfeld J, Wilensky RL, Herrmann HC, Kolansky DM, Rader DJ, Giri J. Prospective CYP2C19 Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical Trial. Circ Genom Precis Med. 2020
  37. Khatana SAM, Bhatla A, Nathan AS, Giri J, Shen C, Kazi DS, Yeh RW, Groeneveld PW. Association of Medicaid Expansion With Cardiovascular Mortality. JAMA Cardiol. 2019
  38. Khatana SAM, Nathan AS, Dayoub EJ, Giri J, Groeneveld PW. Centers of Excellence Designations, Clinical Outcomes, and Characteristics of Hospitals Performing Percutaneous Coronary Interventions. JAMA Intern Med. 2019
  39. Nathan AS*, Khatana SAM*, Yeh RW, Groeneveld PW, Giri J. Hospital-Specific Mortality for Acute Myocardial Infarction Versus Emergency Percutaneous Coronary Intervention in New York State. JACC Cardiovasc Interv. 2019
  40. Nathan AS*, Shah RM*, Khatana SA, Dayoub E, Chatterjee P, Desai ND, Waldo SW, Yeh RW, Groeneveld PW, Giri J. Effect of Public Reporting on the Utilization of Coronary Angiography After Out-of-Hospital Cardiac Arrest. Circ Cardiovasc Interv. 2019
  41. Nathan AS, Geng Z, Dayoub EJ, Khatana SAM, Eberly LA, Kobayashi T, Pugliese SC, Adusumalli S, Giri J, Groeneveld PW. Racial, Ethnic, and Socioeconomic Inequities in the Prescription of Direct Oral Anticoagulants in Patients With Venous Thromboembolism in the United States. Circ Cardiovasc Qual Outcomes. 2019
  42. Dayoub EJ, Nathan AS, Khatana SAM, Seigerman M, Tuteja S, Kobayashi T, Kolansky DM, Groeneveld PW, Giri J. Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009-2016. Circ Cardiovasc Interv. 2019
  43. Khatana SAM, Fiorilli PN, Nathan AS, Kolansky DM, Mitra N, Groeneveld PW, Giri J. Association Between 30-Day Mortality After Percutaneous Coronary Intervention and Education and Certification Variables for New York State Interventional Cardiologists. Circ Cardiovasc Interv. 2018
  44. Lipton JO, Boyle LM, Yuan ED, Hochstrasser KJ, Chifamba FF, Nathan A, Tsai PT, Davis F, Sahin M. Aberrant Proteostasis of BMAL1 Underlies Circadian Abnormalities in a Paradigmatic mTOR-opathy. Cell Rep. 2017
  45. Cunningham JW, Nathan AS, Rhodes J, Shafer K, Landzberg MJ, Opotowsky AR. Decline in peak oxygen consumption over time predicts death or transplantation in adults with a Fontan circulation. Am Heart J. 2017
  46. Resor CD, Nathan A, Kereiakes DJ, Yeh RW, Massaro JM, Cutlip DE, Gabriel Steg P, Hsieh WH, Mauri L; Dual Antiplatelet Therapy Study Investigators. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study. Circulation. 2016
  47. Lipton J, Yuan E, Boyle L, Nathan A, Ebrahimi-Fakhari D, Kwiatkowski E, Guttler T, Davis F, Asara J, Sahin M. “The Circadian Protein BMAL1 Regulates Translation in Response to S6K1-Mediated Phosphorylation.” Cell. 2015
  48. Nathan AS, Loukas B, Moko L, Wu F, Rathod RH, Systrom DM, Ubeda-Tikkanen A, Rhodes J, Lewis GD, Landzberg MJ, Opotowsky AR, “Exercise Oscillatory Ventilation in Patients with Fontan Physiology.” 2014 Circ Heart Failure. 2015
  49. Czarny M, Nathan A, Yeh R, Mauri L. “Adherence to Dual-Antiplatelet Therapy after Coronary Stenting: A Meta-Analysis and Systematic Review.” 2014, Clinical Cardiology. 2014
  50. Nathan AS, Baker BM, Nerurkar NL, Mauck RL. “Mechano-topographic Modulation of Stem Cell Nuclear Shape on Nanofibrous Scaffolds.” Acta Biomateriala. 2011
  51. Baker BM, Nathan AS, Gee AO, Mauck RL. “The Influence of an Aligned Nanofibrous Topography on Human Mesenchymal Stem Cell Fibrochondrogenesis.” Biomaterials. 2010
  52. Baker BM, Nathan AS, Huffman GR, Mauck RL.  “Tissue Engineering with Meniscus Cells Derived from Surgical Debris.” Osteoarthritis and Cartilage. 2009
  53. Baker BM, Gee AO, Metter RB, Nathan AS, Marklein RA, Burdick JA, Mauck RL.  “Selective Removal of Sacrificial Fibers Improves Cell Infiltration in Composite Fiber-Aligned Nanofibrous Scaffolds.” Biomaterials. 2008